- Home
- ILMN vs ALLE Comparison
ILMN vs ALLE Comparison
Compare ILMN & ALLE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ILMN
- ALLE
- Stock Information
- Founded
- ILMN 1998
- ALLE 2013
- Country
- ILMN United States
- ALLE Ireland
- Employees
- ILMN N/A
- ALLE N/A
- Industry
- ILMN Medical Specialities
- ALLE Diversified Commercial Services
- Sector
- ILMN Health Care
- ALLE Consumer Discretionary
- Exchange
- ILMN Nasdaq
- ALLE Nasdaq
- Market Cap
- ILMN 15.3B
- ALLE 15.4B
- IPO Year
- ILMN 2000
- ALLE N/A
- Fundamental
- Price
- ILMN $119.95
- ALLE $164.20
- Analyst Decision
- ILMN Hold
- ALLE Hold
- Analyst Count
- ILMN 15
- ALLE 9
- Target Price
- ILMN $114.93
- ALLE $172.22
- AVG Volume (30 Days)
- ILMN 1.9M
- ALLE 820.6K
- Earning Date
- ILMN 10-30-2025
- ALLE 10-23-2025
- Dividend Yield
- ILMN N/A
- ALLE 1.24%
- EPS Growth
- ILMN N/A
- ALLE 13.70
- EPS
- ILMN 4.46
- ALLE 7.39
- Revenue
- ILMN $4,288,000,000.00
- ALLE $3,979,700,000.00
- Revenue This Year
- ILMN N/A
- ALLE $9.14
- Revenue Next Year
- ILMN $2.74
- ALLE $5.78
- P/E Ratio
- ILMN $26.90
- ALLE $22.29
- Revenue Growth
- ILMN N/A
- ALLE 6.87
- 52 Week Low
- ILMN $68.70
- ALLE $116.57
- 52 Week High
- ILMN $156.66
- ALLE $180.68
- Technical
- Relative Strength Index (RSI)
- ILMN 69.23
- ALLE 33.64
- Support Level
- ILMN $94.00
- ALLE $164.20
- Resistance Level
- ILMN $124.08
- ALLE $173.73
- Average True Range (ATR)
- ILMN 5.00
- ALLE 3.60
- MACD
- ILMN 2.74
- ALLE -1.31
- Stochastic Oscillator
- ILMN 86.51
- ALLE 4.90
About ILMN Illumina Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
About ALLE Allegion plc
Allegion is a global security products company with a portfolio of leading brands such as Schlage, Von Duprin, and LCN. The Ireland-domiciled company was created via a spinoff transaction from Ingersoll-Rand in December 2013. In fiscal 2024, Allegion generated over 75% of sales in the United States. The company primarily competes with Sweden-based Assa Abloy, Switzerland-based Dormakaba, and US-based Fortune Brands Innovations.